Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
McKinsey
Fish and Richardson
Argus Health
Express Scripts
Daiichi Sankyo
UBS
US Department of Justice

Generated: May 23, 2018

DrugPatentWatch Database Preview

CEPHAPIRIN SODIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Cephapirin Sodium patents expire, and when can generic versions of Cephapirin Sodium launch?

Cephapirin Sodium is a drug marketed by Abraxis Pharm and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in CEPHAPIRIN SODIUM is cephapirin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephapirin sodium profile page.
Summary for CEPHAPIRIN SODIUM
Drug patent expirations by year for CEPHAPIRIN SODIUM
Medical Subject Heading (MeSH) Categories for CEPHAPIRIN SODIUM
Synonyms for CEPHAPIRIN SODIUM
(6R-trans)-3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridylthio)acetyl)amino)-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt
(6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium
(7R,7aR)-3-(acetyloxymethyl)-6-oxo-7-(2-(4-pyridylthio)acetylamino)-2H,7H-azet idino[2,1-b]1,3-thiazine-4-carboxylic acid, sodium salt
21593-23-7 (Parent)
24356-60-3
3-[(Acetyloxy)methyl]-8-oxo-7-{(4-pyridinylthio)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt
356C603
431LFF7I7J
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), monosodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridylthio)acetyl)amino)-, monosodium salt, (6R-trans)-
7-(alpha-(4-Pyridylthio)acetamido)cephalosporanic acid sodium salt
AKOS024282660
Ambrocef
Antibiotic BL-P 1322
ANTIBIOTIC BL-P1322
API0000458
BL-P 1322
BL-P-1322
BLP 1322
Brisfirina
Brisporin
Bristocef
C 8270
C08101
CAS-24356-60-3
CCG-38912
Cefa-Lak (Veterinary)
Cefadyl
Cefadyl (TN)
Cefadyl IM/IV
cefapirin sodium
Cefapirin sodium (JAN)
Cefapirin sodium salt
Cefapirin sodium, analytical standard
Cefapirin sodium, European Pharmacopoeia (EP) Reference Standard
Cefapirina sdica
Cefapirinsodium
Cefatrex
Cefatrexyl
Cephapirin sodium (USP)
Cephapirin sodium [USAN:USP]
CEPHAPIRIN SODIUM CRYSTALLINE
Cephapirin sodium salt
Cephapirin sodium, >=96%
Cephapirin sodium, United States Pharmacopeia (USP) Reference Standard
Cephatrexyl
CHEBI:3545
CHEMBL1201043
D00908
DSSTox_CID_25574
DSSTox_GSID_45574
DSSTox_RID_80971
DTXSID7045574
EINECS 246-194-2
EU-0100279
FT-0603005
HE328130
HE351200
HMS1570L03
HMS1920K13
HMS2091A16
HMS500C04
monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate
Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester)
NCGC00017093-01
NCGC00093735-01
NCGC00162116-04
NSC 179171
Prestwick_27
SCHEMBL64430
Sodium (6R-trans)-3-(acetoxymethyl)-8-oxo-7-((4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-{[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium 7-(pyrid-4-ylthioacetamido)cephalosporanate
Sodium cefapirin
Sodium cephapirin
sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1500167
ST057376
Tox21_110772
Tox21_110772_1
UNII-431LFF7I7J

US Patents and Regulatory Information for CEPHAPIRIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm CEPHAPIRIN SODIUM cephapirin sodium INJECTABLE;INJECTION 062723-002 Nov 17, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int CEPHAPIRIN SODIUM cephapirin sodium INJECTABLE;INJECTION 062720-003 Jul 2, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abraxis Pharm CEPHAPIRIN SODIUM cephapirin sodium INJECTABLE;INJECTION 062723-005 Nov 17, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int CEPHAPIRIN SODIUM cephapirin sodium INJECTABLE;INJECTION 062720-004 Jul 2, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
AstraZeneca
Medtronic
Mallinckrodt
Accenture
Federal Trade Commission
Cipla
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.